Back | Next |
home / stock / sonn / sonn message board
Subject | By | Source | When |
---|---|---|---|
Still good things happening so I'll be loading | BooDog | investorshub | 01/20/2023 2:09:47 PM |
Sounds good to me but the stock has | govprs | investorshub | 01/20/2023 1:47:15 PM |
Excerpt : We have evaluated the drug levels | BooDog | investorshub | 01/20/2023 11:23:52 AM |
Shorts worked real hard today inspite of good | govprs | investorshub | 01/20/2023 12:55:14 AM |
Drip, drip, drip. Feels like the dam | Skipman6 | investorshub | 01/12/2023 4:58:21 PM |
Trend lines look to be holding up nicely. | BooDog | investorshub | 01/11/2023 6:45:26 PM |
Jassen and Roche. Whos next? | govprs | investorshub | 01/10/2023 5:18:06 AM |
NEWS! Sonnet BioTherapeutics Announces a Collaboration with Roche | BooDog | investorshub | 01/09/2023 1:42:37 PM |
Shorts are back lol | govprs | investorshub | 01/06/2023 4:15:46 PM |
Lets Go! | govprs | investorshub | 01/05/2023 6:31:01 PM |
Looking good!! | BooDog | investorshub | 01/05/2023 6:22:47 PM |
Exactly my thinking. | govprs | investorshub | 11/22/2022 9:03:02 PM |
Now I wait for the chart. Or I | BooDog | investorshub | 11/22/2022 8:57:19 PM |
This could still see under the $ but | BooDog | investorshub | 11/22/2022 4:29:31 PM |
Shorting going on today. Im buying | govprs | investorshub | 11/08/2022 1:31:10 AM |
Oh man I guess the gap filled. | govprs | investorshub | 11/07/2022 2:46:46 PM |
Pre market sell off. When will the | govprs | investorshub | 11/07/2022 1:29:57 PM |
I did add a few shares today @ 1.55 | govprs | investorshub | 11/04/2022 5:32:06 PM |
Im add as funds permit. Timing wont | govprs | investorshub | 11/04/2022 5:05:36 PM |
The real gap is actually much lower. | BooDog | investorshub | 11/04/2022 11:20:47 AM |
News, Short Squeeze, Breakout and More Instantly...
Sonnet BioTherapeutics Holdings Inc. Company Name:
SONN Stock Symbol:
NASDAQ Market:
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"...
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic drugs, announced today that the SB221 study of SON-1010 (recombinant human Interleukin-12 linked t...
PRINCETON, NJ / ACCESSWIRE / May 22, 2024 / Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the "Company" or "Sonnet"), a clinical-stage company developing targeted immunotherapeutic drugs, announced today that its Board of Directors has initiated a process to explore and review a range of ...